Multi-Constrained Evolutionary Molecular Design Framework: An Interpretable Drug Design Method Combining Rule-Based Evolution and Molecular Crossover

2026-01-15

AI Summary

This work proposes MCEMOL, a novel framework addressing the limitations of conventional deep learning–based drug design approaches—namely their heavy reliance on large datasets, high computational cost, and poor interpretability. MCEMOL introduces a dual-layer evolutionary mechanism that uniquely integrates interpretable rule evolution with molecular structural crossover operations. By combining message-passing neural networks, rule-level evolution, and molecular crossover and mutation strategies—while embedding chemical and pharmacophoric constraints—the method efficiently generates novel compounds from only a small set of initial molecules. The generated molecules are 100% chemically valid, exhibit high structural diversity and favorable drug-like properties, and demonstrate superior performance in symmetry, pharmacophore matching, and stereochemical integrity, thereby ensuring both scientific credibility and practical utility.

Technology Category

Machine Learning: Deep Neural Architectures and Foundation ModelsSearch and Optimization: Evolutionary ComputationCognitive Modeling & Cognitive Systems: Computational Creativity

Application Category

Graph Algorithms and Modeling for the Web: Graph neural networks and deep learning approaches for Web-related graphsSearch and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for rankingEconomics, Online Markets and Human Computation: Incentives in network design for Web infrastructures and ecosystems

Abstract

This study proposes MCEMOL (Multi-Constrained Evolutionary Molecular Design Framework), a molecular optimization approach integrating rule-based evolution with molecular crossover. MCEMOL employs dual-layer evolution: optimizing transformation rules at rule level while applying crossover and mutation to molecular structures. Unlike deep learning methods requiring large datasets and extensive training, our algorithm evolves efficiently from minimal starting molecules with low computational overhead. The framework incorporates message-passing neural networks and comprehensive chemical constraints, ensuring efficient and interpretable molecular design. Experimental results demonstrate that MCEMOL provides transparent design pathways through its evolutionary mechanism while generating valid, diverse, target-compliant molecules. The framework achieves 100% molecular validity with high structural diversity and excellent drug-likeness compliance, showing strong performance in symmetry constraints, pharmacophore optimization, and stereochemical integrity. Unlike black-box methods, MCEMOL delivers dual value: interpretable transformation rules researchers can understand and trust, alongside high-quality molecular libraries for practical applications. This establishes a paradigm where interpretable AI-driven drug design and effective molecular generation are achieved simultaneously, bridging the gap between computational innovation and practical drug discovery needs.

Problem

• interpretable drug design
• molecular optimization
• chemical constraints
• molecular validity
• drug-likeness

Innovation

• interpretable drug design
• rule-based evolution
• molecular crossover
• multi-constrained optimization
• message-passing neural networks